Updates in advances in lung cancer
Updates in advances in lung cancer:

Lung cancer remains a major cause of cancer deaths throughout the world. It is an extremely lethal neoplasm: 80–90% of patients who develop lung cancer will die of their disease.The purpose of this book is to update cancer specialists, pulmonary physicians, thoracic surgeons and general practitioner...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Schiller, Joan H. (HerausgeberIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Basel Karger 1997
Schriftenreihe:Progress in respiratory research Vol. 29
Schlagworte:
Respiratory System
Chemotherapy
Oncology
Internal Medicine
Molecular Biology
Surgery
Thoracic Surgery
Lungenkrebs
Aufsatzsammlung
Online-Zugang:DE-522
DE-12
DE-526
DE-521
DE-1102
DE-1046
DE-1028
DE-573
DE-M347
DE-92
DE-898
DE-859
DE-1049
DE-863
DE-862
DE-M382
DE-70
DE-128
DE-54
DE-22
DE-155
DE-150
DE-91
DE-384
DE-473
DE-19
DE-355
DE-703
DE-20
DE-706
DE-29
DE-739
Volltext
Zusammenfassung:Lung cancer remains a major cause of cancer deaths throughout the world. It is an extremely lethal neoplasm: 80–90% of patients who develop lung cancer will die of their disease.The purpose of this book is to update cancer specialists, pulmonary physicians, thoracic surgeons and general practitioners about the many recent advances in the treatment, prevention and biology of lung cancer. Despite the overall poor prognosis for patients, a number of new chemotherapeutic drugs and regimens have been developed which result in a clinically meaningful improvement in survival for patients with nonsmall cell lung carcinoma. Four chapters in this book are devoted to reviewing these new drugs and drug combinations (paclitaxel, docetaxel, vinorelbine, gemcitabine, topoisomerase inhibitors). Advances in the management of locally advanced nonsmall cell and small cell lung cancer are considered, including combined-modality treatments using chemotherapy, surgery, and radiation therapy. Results of recent trials involving chemoprevention agents are also reported. Finally, the latest progress in understanding the molecular biology of this disease, and how it might impact on the clinical management of lung cancer patients, is discussed
Beschreibung:evaluating new chemotherapeutic regimens for treatment and prevention
Beschreibung:1 Online-Ressource (X, 192 Seiten) Diagramme
ISBN:9783318002546
Login für die Nachverfolgung von Bestellungen und Vormerkungen
Volltext öffnen

Ähnliche Einträge